Sofgen Pharma S.A.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation Luxembourg
Country Luxembourg
Business Address 9 RUE DE BITBOURG, LUXEMBOURG, ,
Mailing Address 9 RUE DE BITBOURG, LUXEMBOURG, ,
Phone 575-371-9280
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 19, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
Annual Reports
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.